MatsukiyoCocokara & Co operates retail drugstores and insurance dispensing pharmacies in Japan... Show more
The Stochastic Oscillator for MSMKF moved out of overbought territory on November 13, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 8 similar instances where the indicator exited the overbought zone. In of the 8 cases the stock moved lower. This puts the odds of a downward move at .
The 10-day RSI Indicator for MSMKF moved out of overbought territory on November 18, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 6 similar instances where the indicator moved out of overbought territory. In of the 6 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
MSMKF moved below its 50-day moving average on November 18, 2025 date and that indicates a change from an upward trend to a downward trend.
The Momentum Indicator moved above the 0 level on October 21, 2025. You may want to consider a long position or call options on MSMKF as a result. In of 6 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for MSMKF just turned positive on October 20, 2025. Looking at past instances where MSMKF's MACD turned positive, the stock continued to rise in of 7 cases over the following month. The odds of a continued upward trend are .
The 10-day moving average for MSMKF crossed bullishly above the 50-day moving average on November 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 6 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MSMKF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.150) is normal, around the industry mean (6.341). P/E Ratio (20.089) is within average values for comparable stocks, (44.968). MSMKF's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.494). Dividend Yield (0.017) settles around the average of (0.027) among similar stocks. P/S Ratio (1.044) is also within normal values, averaging (6.452).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MSMKF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
Industry DrugstoreChains
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SH | 37.56 | 0.31 | +0.83% |
| ProShares Short S&P500 | |||
| GAPR | 39.32 | -0.04 | -0.10% |
| FT Vest U.S. Eq Mod Buf ETF - Apr | |||
| ZMAY | 25.15 | -0.03 | -0.12% |
| Innovator Equity Dfnd Prt ETF -1 Yr May | |||
| CPSD | 25.70 | -0.04 | -0.14% |
| Calamos S&P 500 Str Alt Prt ETF-Dec | |||
| IGTR | 25.78 | -0.23 | -0.89% |
| Innovator Gradient Tactical Rot Str ETF | |||
A.I.dvisor tells us that MSMKF and HITI have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MSMKF and HITI's prices will move in lockstep.
| Ticker / NAME | Correlation To MSMKF | 1D Price Change % | ||
|---|---|---|---|---|
| MSMKF | 100% | -8.28% | ||
| HITI - MSMKF | 8% Poorly correlated | +3.80% | ||
| CLCGY - MSMKF | 3% Poorly correlated | -3.61% | ||
| ALBBY - MSMKF | 0% Poorly correlated | N/A | ||
| HEWA - MSMKF | 0% Poorly correlated | N/A | ||
| PETS - MSMKF | -2% Poorly correlated | -5.10% | ||
More | ||||